Get the Stockscreener App
1.61
4.55%
0.07
Pre-market:
1.59
-0.02
-1.24%
Maxcyte Inc stock is traded at $1.61, with a volume of 757.63K.
It is up +4.55% in the last 24 hours and down -5.85% over the past month.
MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.
See More
Previous Close:
$1.54
Open:
$1.54
24h Volume:
757.63K
Relative Volume:
0.90
Market Cap:
$171.64M
Revenue:
$45.44M
Net Income/Loss:
$-35.43M
P/E Ratio:
-4.7353
EPS:
-0.34
Net Cash Flow:
$-25.39M
1W Performance:
+4.55%
1M Performance:
-5.85%
6M Performance:
-42.91%
1Y Performance:
-57.29%
1-Day Range:
$1.45
$1.61
1-Week Range:
$1.45
$1.61
52-Week Range:
$1.26
$5.20
Maxcyte Inc Stock (MXCT) Company Profile
Name
Maxcyte Inc
Sector
Industry
Phone
301-517-5556
Address
9713 KEY WEST AVENUE,, ROCKVILLE
Compare MXCT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MXCT
Maxcyte Inc
|
1.61 | 164.17M | 45.44M | -35.43M | -25.39M | -0.34 |
|
ABT
Abbott Laboratories
|
123.84 | 214.96B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.59 | 149.24B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
358.16 | 136.23B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
90.20 | 116.33B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
83.07 | 48.41B | 5.88B | 1.34B | 577.90M | 2.3455 |
Maxcyte Inc Stock (MXCT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-11-25 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-07-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-22-25 | Initiated | Stephens | Overweight |
| Nov-29-23 | Initiated | Craig Hallum | Buy |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Aug-24-21 | Initiated | BTIG Research | Buy |
| Aug-24-21 | Initiated | Cowen | Outperform |
| Aug-24-21 | Initiated | Stephens | Overweight |
| Aug-24-21 | Initiated | Stifel | Buy |
| Aug-24-21 | Initiated | Wedbush | Outperform |
| Aug-24-21 | Initiated | William Blair | Outperform |
View All
Maxcyte Inc Stock (MXCT) Latest News
What MACD signals say about MaxCyte Inc.Portfolio Performance Summary & Fast Moving Trade Plans - newser.com
Will MaxCyte Inc. stock split again soonEarnings Trend Report & Daily Oversold Stock Bounce Ideas - newser.com
How to interpret RSI for MaxCyte Inc. stockMarket Weekly Review & Fast Entry High Yield Stock Tips - newser.com
MaxCyte unveils Flow Electroporation tech at KSGCT meeting - Traders Union
MaxCyte Inc expected to post a loss of 11 cents a shareEarnings Preview - TradingView
What Wall Street predicts for MaxCyte Inc. stock priceWeekly Profit Analysis & Stock Portfolio Risk Management - newser.com
Will breakout in MaxCyte Inc. lead to full recoveryJuly 2025 Action & Smart Swing Trading Techniques - newser.com
Reversal indicators forming on MaxCyte Inc. stockGap Up & Free Expert Approved Momentum Trade Ideas - newser.com
Can MaxCyte Inc. (MYE0) stock stage a strong rebound this quarterPortfolio Return Summary & Precise Entry and Exit Recommendations - newser.com
Real time scanner hits for MaxCyte Inc. explained2025 Risk Factors & AI Powered Market Entry Strategies - newser.com
Technical analysis overview for MaxCyte Inc. stock2025 Technical Overview & High Accuracy Trade Alerts - newser.com
Will MaxCyte Inc. (MYE0) stock outperform benchmarksGlobal Markets & Entry Point Confirmation Signals - newser.com
What dividend safety rating applies to MaxCyte Inc. (MYE0) stock2025 Earnings Surprises & Stepwise Trade Signal Guides - newser.com
Why MaxCyte Inc. stock could outperform in 2025Trade Signal Summary & Real-Time Volume Triggers - newser.com
Will MaxCyte Inc. (MYE0) stock see valuation expansion2025 AllTime Highs & Consistent Return Investment Signals - newser.com
How buyback programs support MaxCyte Inc. (MYE0) stockChart Signals & Daily Entry Point Alerts - newser.com
Backtesting results for MaxCyte Inc. trading strategiesWeekly Trade Recap & Fast Entry Momentum Trade Alerts - newser.com
Statistical indicators supporting MaxCyte Inc.’s strengthJuly 2025 PreEarnings & Real-Time Volume Trigger Notifications - newser.com
Is MaxCyte Inc. stock a buy in volatile marketsJuly 2025 Trade Ideas & Real-Time Market Sentiment Alerts - newser.com
Can MaxCyte Inc. stock deliver strong Q4 earningsMarket Rally & Entry Point Confirmation Alerts - newser.com
Why MaxCyte Inc. stock remains a top recommendation2025 Support & Resistance & Fast Entry Momentum Trade Alerts - newser.com
Can MaxCyte Inc. stock resist market sell offsQuarterly Earnings Report & Verified Trade Idea Suggestions - newser.com
MaxCyte (MXCT) Projected to Post Quarterly Earnings on Wednesday - MarketBeat
Maxcyte Inc Stock (MXCT) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.84%
0.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):